Forefront Medical Technology

Home » Newsletter

Category Archives: Newsletter

Q3 2020 Newletter

Q3 2020 Forefront newsletter

This quarter’s On the Forefront newsletter looks at two COVID-19 related projects that Forefront has currently supported with rapid production ramp-ups. Forefront’s robust process for project commercialization is discussed in detail. There is also a brief overview of the recent visit of Singapore’s Deputy Prime Minister to Forefront’s Singapore headquarters and production facility. Read the full issue here.

Q2 2020 Newsletter

Q2 2020 Forefront newsletter

This quarter’s On the Forefront newsletter includes a case study that discusses the ways that changing the manufacturing strategy for a specialized drug infusion set reduced cost and improved overall quality. Forefront’s ability to help customers reduce total cost by optimizing the value stream to eliminate inefficiencies is also covered. Finally, there is a roundup of Forefront’s latest news coverage. Read the full issue here.

Q1 2020 Newsletter

Q1 2020 Forefront newsletter

This quarter’s issue of On the Forefront looks at Forefront Medical Technology’s six week journey in restarting its China manufacturing following the COVID-19 infection in China. It also looks at Forefront’s worldwide network of facilities and its ability to support a broad range of new product development technologies in its Singapore engineering and manufacturing facility. Read the full issue here.

Q4 2019 Newsletter

Q4 2019 Forefront newsletterThis quarter’s issue of On the Forefront, explores the advantages of Forefront Medical’s electromechanical box build design and assembly capabilities. Combined with our precision engineering expertise, these capabilities enable companies with electromechanical products that incorporate fluidics or other precision engineered parts, to have a one-stop source for product commercialization. Read more about our capabilities here.

Q32019 Newsletter

Q3 2019 Forefront newsletter_Page_1

The latest issue of Forefront Medical Technology’s newsletter is available for download. In this issue, we look at outsourcing and intellectual property protection, discussing key issues such as product design ownership, contract manufacturing business models that may provide better IP protection and the benefits of a legal framework that supports IP protection. Read the full issue here.

Q22019 Newsletter

Q2 2019 Forefront newsletterForefront Medical Technology’s latest newsletter looks at outsourcing strategy and lesser known drivers of cost reduction such as leveraging free trade agreement advantages, scalable automation, supply chain realignment and improved logistics efficiency. Read the full issue here.

Q12019 Newsletter

Q1 2019 Forefront newsletterForefront Medical Technology’s Q1 2019 newsletter provides a quick overview of RoHS 3 and its impact on plasticizers known as phthalates and a look at the “business case” behind good outsourcing strategy. Forefront’s 20% stake in Arrow Medical Limited in the U.K, is also discussed. Read the full issue here.

Q4 2108 Newsletter

Q4 2018 Forefront newsletter

Forefront Medical Technology’s Q4 2018 newsletter describes some of the building blocks of world class quality that drive our Quest for Excellence. It also discusses the ways our global approach to quality management helps customers wishing to enter new markets. Read the full issue here.

Q3 2018 Newsletter

Q3 2018 Forefront newsletter

Forefront’s Q3 2018 newsletter looks at the process of ensuring the voice of the customer is a strong part of the product development and commercialization process. This issue also discusses five ways to reduce tooling cost and trends in extrusion. Read the full issue here.

Q2 2018 Newsletter

Q2 2018 Forefront newsletterForefront Medical Technology’s Q2 2018 newsletter is out. The issue includes a list of questions to ask to determine if a contract manufacturer is a good fit for your project’s requirements, the design benefits of selecting a contract manufacturer with a broad range of production capabilities and a case study related to a specialty drug delivery system. Read the full issue here.